News
13h
Zacks.com on MSNTempus AI Raises 2025 Financial Outlook: What's Backing It?Tempus AI TEM expects full-year 2025 revenues of $1.25 billion (up from the previous $1.24 billion guidance), which represents approximately 80% annual growth. The company also expects adjusted EBITDA ...
Tempus AI Inc. (NASDAQ:TEM) is one of the best young stocks to buy and hold for 5 years. On July 8, Tempus AI announced the ...
Key Takeaways Tempus AI stock shows 15–32% upside potential based on analyst forecasts.The company leads in using artificial ...
12h
Investor's Business Daily on MSNTempus AI Earns Relative Strength Rating UpgradeTempus AITEM reached an important technical milestone, with its Relative Strength (RS) Rating moving into the 90-plus ...
Guggenheim analyst Subbu Nambi reaffirmed a “Buy” rating on Tempus AI, Inc. (NASDAQ:TEM), while raising the firm’s price ...
One of Wood's favorite AI stocks has been criticized by CNBC host Jim Cramer multiple times in 2025, including this week.
In a statement, Tempus AI, Inc. (NASDAQ:TEM) said that it plans to raise the funds through a convertible senior notes ...
Apple's $60 billion cash pile and a rare executive shake-up reignite speculation: will the tech giant finally go on an AI ...
12d
TipRanks on MSNTempus AI Announces $400 Million Convertible Notes OfferingMake smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.The latest update is out from Tempus AI, Inc. Class A ( (TEM) ). On June 30, 2025, Tempus AI ...
Tempus AI is revolutionizing AI healthcare through genomics innovation and strong financial growth. Click here to read an analysis of TEM stock now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results